切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2016, Vol. 04 ›› Issue (01) : 45 -47. doi: 10.3877/cma.j.issn.2095-655X.2016.01.013

所属专题: 文献

临床研究

胃炎、食管炎和食管癌患者血清中人丝氨酸蛋白酶8的表达及临床意义
李凯1, 赵卫星1, 鲍永华2, 杨万才3,()   
  1. 1. 453100 新乡医学院第一附属医院病理科
    2. 453003 新乡医学院基础医学院免疫学教研室
    3. 453003 新乡医学院基础医学院病理教研室
  • 收稿日期:2015-12-03 出版日期:2016-02-26
  • 通信作者: 杨万才
  • 基金资助:
    国家自然科学基金(91229115)

The serum levels of PRSS8 and their clinical significance in the patients with gastritis, esophagitis and esophageal cancer

Kai Li1, Weixing Zhao1, Yonghua Bao2, Wancai Yang3,()   

  1. 1. Department of Pathology, the First Affiliated Hospital of Xinxiang Medical University, Weihui 453100
    2. Department of Immunology, Xinxiang Medical University, Xinxiang 453003, China
    3. Department of Pathology, Xinxiang Medical University, Xinxiang 453003, China
  • Received:2015-12-03 Published:2016-02-26
  • Corresponding author: Wancai Yang
  • About author:
    Corresponding author: Yang Wancai, Email:
引用本文:

李凯, 赵卫星, 鲍永华, 杨万才. 胃炎、食管炎和食管癌患者血清中人丝氨酸蛋白酶8的表达及临床意义[J]. 中华诊断学电子杂志, 2016, 04(01): 45-47.

Kai Li, Weixing Zhao, Yonghua Bao, Wancai Yang. The serum levels of PRSS8 and their clinical significance in the patients with gastritis, esophagitis and esophageal cancer[J]. Chinese Journal of Diagnostics(Electronic Edition), 2016, 04(01): 45-47.

目的

探讨人丝氨酸蛋白酶8(PRSS8)在胃炎、食管炎和食管癌患者血清中的表达情况及意义。

方法

采集临床诊断为食管炎、食管癌和胃炎患者以及正常人群的血清样本,其中食管炎患者血清样本20例,食管癌患者血清样本6例,胃炎患者血清样本60例,正常血清样本28例。采用酶联免疫吸附法(ELISA)的方法测定各组中PRSS8的表达水平,并将食管炎患者组、食管癌患者组和胃炎患者组分别与正常组相比较。

结果

各组血清PRSS8表达水平差异有统计学意义(F=13.24,P<0.01)。食管炎患者组PRSS8表达水平[(4.58±1.67)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=2.59,P<0.05);食管癌患者组PRSS8表达水平[(5.05±0.57)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=2.54,P<0.05);食管癌患者组PRSS8表达水平[(5.05±0.57)μg/L]高于食管炎患者组[(4.58±1.67)μg/L],差异无统计学意义(LSD-t=0.83,P>0.05);胃炎患者组PRSS8表达水平[(5.39±1.04)μg/L]高于正常组[(3.52±1.49)μg/L],差异有统计学意义(LSD-t=6.22,P<0.05)。

结论

食管炎、食管癌和胃炎患者血清中PRSS8表达水平均增高,提示血清中的PRSS8可能与食管炎、食管癌和胃炎的发生发展相关。

Objective

To study the expression level and significance of serum human protease serine 8(PRSS8) in the patient with gastritis, esophagitis and esophageal cancer.

Methods

The serum samples from healthy subjects and the patients diagnosed as esophagitis, esophageal cancer and gastritis were collected.The serum samples included 20 esophagitis serum samples, 6 esophageal cancer serum samples, 60 gastritis serum samples and 28 healthy serum samples.The expression level of PRSS8 was detected by ELISA assay.Then the serum PRSS8 levels from the esophagitis group, esophageal cancer group and the gastritis group were compared with the healthy group, respectively.

Results

The serum level of PRSS8 in esophagitis group [(4.58±1.67)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was statistically significant(LSD-t=2.59, P<0.05). The serum level of PRSS8 in esophageal cancer group [(5.05±0.57)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was statistically significant(LSD-t=2.54, P<0.05). The serum level of PRSS8 in esophageal cancer group [(5.05±0.57)μg/L] was higher than that from the esophagitis group [(4.58±1.67)μg/L], the difference was not statistically significant(LSD-t=0.83, P>0.05). The level of serum PRSS8 in gastritis group [(5.39±1.04)μg/L] was higher than that from the healthy group [(3.52±1.49)μg/L], the difference was also statistically significant (LSD-t=6.22, P<0.05).

Conclusion

Serum PRSS8 expression levels are obviously increased in the patients with esophagitis, esophageal cancer and gastritis, which suggests that serum PRRS8 maybe relate to the development of esophagitis, esophageal cancer and gastritis.

表1 各组间血清PRSS8水平比较(μg/L,±s)
[1]
Yu JX,Chao L,Chao J. Prostasin is a novel human serine protease from seminal fluid.Purification, tissue distribution, and localization in prostate gland[J]. J biol chem, 1994, 269(29): 18843-18848.
[2]
Hooper JD,Bowen N,Marshall H, et al.Localization, expression and genomic structure of the gene encoding the human serine protease testisin[J]. Biochim Biophys Acta, 2000, 1492(1): 63-71.
[3]
Yu JX,Chao L,Ward DC, et al.Structure and chromosomal localization of the human prostasin (PRSS8) gene[J]. Genomics, 1996, 32(3): 334-340.
[4]
Yu JX,Chao L,Chao J. Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA[J]. J Biol Chem, 1995, 270(22): 13483-13489.
[5]
Leyvraz C,Charles RP,Rubera I, et al.The epidermal barrier function is dependent on the serine protease CAP1/Prss8[J]. J Cell Biol, 2005, 170(3): 487-496.
[6]
Buzza MS,Martin EW,Driesbaugh KH, et al.Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway[J]. J Biol Chem, 2013, 288(15): 10328-10337.
[7]
Chen LM,Hatfield ML,Fu YY, et al.Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells[J]. Prostate, 2009, 69(16): 1790-1801.
[8]
Chen LM,Wang C,Chen M, et al.Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation[J]. Am J Physiol Renal Physiol, 2006, 291(3): F567-577.
[9]
Sakashita K,Mimori K,Tanaka F, et al.Clinical significance of low expression of prostasin mRNA in human gastric cancer[J]. J Surg Oncol, 2008, 98(7): 559-564.
[10]
Takahashi S,Suzuki S,Inaguma S, et al.Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers[J]. Prostate, 2003, 54(3): 187-193.
[11]
Chen LM,Verity NJ,Chai KX.Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT) [J]. BMC cancer, 2009(9): 377.
[12]
Chen LM,Chai KX.Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation[J]. Int J Cancer, 2002, 97(3): 323-329.
[13]
López-Otín C,Matrisian LM.Emerging roles of proteases in tumour suppression[J]. Nat Rev Cancer, 2007, 7(10): 800-808.
[14]
Sarojini S,Tamir A,Lim H, et al.Early detection biomarkers for ovarian cancer[J]. J Oncol, 2012: 709049.
[15]
Yan BX,Ma JX,Zhang J, et al.Prostasin may contribute to chem oresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin[J]. Cell Death Dis, 2014(5): e995.
[16]
Chen PX,Li QY,Yang Z. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma[J]. Ann Diagn Pathol, 2013, 17(5): 425-429.
[1] 高建松, 陈晓晓, 冯婷, 包剑锋, 魏淑芳, 潘林. 基于超声瞬时弹性成像的多参数决策树模型评估慢性乙型肝炎患者肝纤维化等级[J]. 中华医学超声杂志(电子版), 2023, 20(09): 923-929.
[2] 史博慧, 丁西萍, 王恋, 李茸, 郭萍利, 齐晶, 陈瑶, 郝娜, 任予. 乳腺癌术后皮下积液防治的最佳证据总结[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 277-284.
[3] 葛飞霞, 蒋银, 杨丹. 酶联免疫吸附测定法与PCR仪检测在乙型肝炎诊断中的临床应用[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 310-315.
[4] 刘星, 吴立胜, 王炜林, 李猛. 远端疝囊残端固定与游离对腹股沟斜疝TAPP术后血清肿的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 550-553.
[5] 陈滔, 罗洪, 周进军. 老年食管癌单纯放疗及同期放化疗患者急性不良反应影响因素分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 405-407.
[6] 黄勇, 郑智, 张海翘, 王龙, 辛城霖, 刘小野, 尹杰, 张军. 近端胃切除术后消化道重建方式的研究进展[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 456-460.
[7] 王可, 范彬, 李多富, 刘奎. 两种疝囊残端处理方法在经腹腹膜前腹股沟疝修补术中的疗效比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 692-696.
[8] 张一忠, 叶乐斌, 帅勇锋, 陈军杰, 唐健松, 俞振良, 吴卫东. 直疝假疝囊四针固定法在单孔腹腔镜腹股沟疝中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 423-426.
[9] 黄承路, 廖飞, 刘显平, 王志强. 血清外泌体Has_circ_0060937过度表达与NSCLC转移和不良预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 490-494.
[10] 陈坤, 何傅梅, 方婷, 陈文瑞. 血清sCD73与EGFR/ALK野生型非小细胞肺癌免疫治疗效果的相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 504-507.
[11] 安钱, 徐彬, 陈志祥, 徐晶晶, 黄丹丹. PCT、CRP及SAA对呼吸机相关性肺炎病情严重程度和预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 544-546.
[12] 辛彩焕, 熊辉. 非疫区36例布鲁菌病患者的临床特征及诊疗分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 927-931.
[13] 王丽芳, 宁武, 丁艳, 张彦霞, 马豆豆, 卢哲敏, 韩芃, 李超然, 王宽婷. 北京市石景山区中学生的血尿酸与血清25(OH)D3水平的相关性研究[J]. 中华临床医师杂志(电子版), 2023, 17(08): 865-869.
[14] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[15] 王欣, 刘琳, 闻哲嘉, 刘春玲, 张弘, 吕芳. 妊娠前应激暴露对小鼠后续妊娠的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 431-437.
阅读次数
全文


摘要